article thumbnail

Biotechnology and Today's Warfighter

The Rand Blog

Biotechnology has a broad and often misunderstood scope, one with significant implications for today's warfighter, and it may be reaching a critical junction. As it continues to mature, proactive policy becomes necessary for the federal government to leverage emerging capabilities effectively and remain competitive.

article thumbnail

Artificial Intelligence and Biotechnology: Risks and Opportunities

The Rand Blog

Machine learning is helping scientists make sense of the genetic keys that could unlock new crops, new drugs, and vaccines. But policymakers may not be prepared for the impact those two fields could have together. To make the most of the opportunities to come, and to avoid the dangers, that has to change.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Range Biotechnologies Raises $5.2M to Advance Proteomics for Precision Health

HIT Consultant

What You Should Know: Range Biotechnologies (Range Bio) announced $5.2M in seed funding, led by TechBio-focused ARTIS Ventures with participation from Pear VC , Page One Ventures , Civilization Ventures , Pillar , Four Cities Capital , Hawktail , and others.

article thumbnail

FTC’s Proposed Non-Compete Rule: A Step in the Right Direction for Health Care and Biotechnology

Bill Of Health

Banning non-compete clauses may help to promote competition and innovation in biotechnology and health care. Currently, there is a high degree of knowledge concentration in new and evolving technologies in the biotechnology sector.

article thumbnail

From Soccer to AI, Saudi Arabia Spends to Win

The Rand Blog

The Saudis have set their sights on becoming leaders at the cutting edge of technology development in everything from biotechnology to semiconductors and artificial intelligence. And they appear to be prepared to pay top dollar to do it. This complicates U.S. critical technology strategy.

article thumbnail

We All Stand to Benefit from Biden’s $2 Billion Bet on the Bioeconomy

Bill Of Health

Business is bustling for biotechnology and biomanufacturing. On September 12, 2022, President Biden signed an executive order , launching a “whole-of-government approach to advance biotechnology and biomanufacturing.” Biotechnology regulation. By Matthew Chun. Bio-related data set development and management.

article thumbnail

ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics

HIT Consultant

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,